Kano, Pfizer meet over progress in research centre project
Kano State government and Pfizer have held their routine yearly meeting to highlight the progress of work in the Kano Independent Research Centre Trust (KIRCT).
Suggestions
Pfizer-BioNTech begin Omicron vaccine trial
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in
Pfizer-BioNTech begin Omicron vaccine trial
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in
S.Africa’s Aspen releases first batch of Johnson vaccine
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced Covid-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said
S.Africa’s Aspen releases first batch of Johnson vaccine
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced Covid-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said
Lessons from COVID-19 vaccines to date
The government of Mongolia promised its people a COVID free summer; Bahrain said there would be a return to normal life by June 2021. The island nation of Seychelles aimed to jump
Lessons from COVID-19 vaccines to date
The government of Mongolia promised its people a COVID free summer; Bahrain said there would be a return to normal life by June 2021. The island nation of Seychelles aimed to jump
Pfizer pushes for 3rd shot as variant drives global outbreaks
Pfizer and BioNTech announced they would seek authorization for a third dose of their Covid-19 vaccine to boost its efficacy, as the Delta variant drove devastating outbreaks in Asia and Africa and
Pfizer pushes for 3rd shot as variant drives global outbreaks
Pfizer and BioNTech announced they would seek authorization for a third dose of their Covid-19 vaccine to boost its efficacy, as the Delta variant drove devastating outbreaks in Asia and Africa and
Mass ‘real world’ study confirms Pfizer vaccine’s efficacy
The Pfizer Covid-19 vaccine proved 94 percent effective in a huge real-world study published Wednesday that involved 1.2 million people in Israel, confirming the power of mass immunization campaigns to end the
Mass ‘real world’ study confirms Pfizer vaccine’s efficacy
The Pfizer Covid-19 vaccine proved 94 percent effective in a huge real-world study published Wednesday that involved 1.2 million people in Israel, confirming the power of mass immunization campaigns to end the